
==== Front
Front Immunol
Front Immunol
Front. Immunol.
Frontiers in Immunology
1664-3224
Frontiers Media S.A.

10.3389/fimmu.2024.1480131
Immunology
Retraction
Retraction: Corrigendum: Natural killer cell-derived exosomal miR-3607-3p inhibits pancreatic cancer progression by targeting IL-26
Frontiers Editorial Office *

Approved by: Luigi Daniele Notarangelo, National Institute of Allergy and Infectious Diseases (NIH), United States

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org
19 8 2024
2024
19 8 2024
15 148013113 8 2024
13 8 2024
Copyright © 2024 Frontiers Editorial Office
2024
Frontiers Editorial Office
https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Retraction of the Corrigendum Article Corrigendum: Natural killer cell-derived exosomal miR-3607-3p inhibits pancreatic cancer progression by targeting IL-26 By Sun H, Shi K, Qi K, Kong H, Zhang J, Dai S, Ye W, Deng T, He Q and Zhou M (2020). Front. Immunol. 11:277. doi: 10.3389/fimmu.2020.00277 section-in-acceptanceCancer Immunity and Immunotherapy
==== Body
pmcFollowing publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

This retraction was approved by the Chief Editors of Frontiers in Immunology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.
